Acutus Medical Reports First Quarter 2021 Financial Results
CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2021.
Recent Highlights:
Reported revenue of $3.6 million in the first quarter of 2021, compared to $1.6 million in the same quarter last year.
Increased worldwide installed base of second generation AcQMap consoles to 57 as of March 31, 2021, up from 51 at the end of the prior quarter – bringing the total installed base of AcQMap consoles to 62 as of March 31, 2021.
Commenced US IDE trial for the AcQBlate Force-Sensing Ablation Catheter and System.